| Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YHR109W | CTM1 | SGDID:S000001151 | BN1205_038210 TGVEG_216080 |
BN1205_038210 TGVEG_216080 |
Toxoplasma gondii | 6fnd_b | B9Q0K5 | 98.40 | 3.10E-11 | 4.20E-15 | 108.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YHR109W | CTM1 | SGDID:S000001151 | A612L |
A612L |
Paramecium bursaria | 2g46_b | O41094 | 95.70 | 7.50E-05 | 9.70E-09 | 56.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YHR109W | CTM1 | SGDID:S000001151 | Smyd1 Bop |
Histone-lysine N-methyltransferase Smyd1 (EC 2.1.1.354) (CD8b-opposite) (SET and MYND domain-containing protein 1) (Zinc finger protein BOP) (m-BOP) |
2.1.1.354 | Mus musculus | 3n71_a | P97443 | 98.30 | 1.10E-10 | 1.50E-14 | 107.10 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
| YHR109W | CTM1 | SGDID:S000001151 | EZH2 KMT6 |
Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6) |
2.1.1.356 | Homo sapiens | Skin Melanoma,Retinitis Pigmentosa,Cll/Sll,Chronic Myelomonocytic Leukemia,Melanoma,Breast Myoepithelial Carcinoma,Clear Cell Renal Cell Carcinoma,Diffuse Midline Glioma, H3 K27m-Mutant,B-Cell Lymphoma,Atypical Teratoid Rhabdoid Tumor,Essential Thrombocythemia,Posterior Fossa Ependymoma,Cholangiolocellular Carcinoma,Neuroblastoma,Primary Cutaneous Follicle Center Lymphoma,Leukemia, Acute Myeloid,Secondary Hemophagocytic Lymphohistiocytosis,Bone Marrow Cancer,Transitional Cell Carcinoma,Ezh2-Related Overgrowth,Bladder Cancer,Bile Duct Adenoma,Primary Hyperoxaluria,Ovarian Cancer,T-Cell Acute Lymphoblastic Leukemia,Breast Cancer,Colorectal Cancer,Hepatocellular Carcinoma,Malignant Peripheral Nerve Sheath Tumor,Rhabdomyosarcoma,Weaver Syndrome,Tongue Disease,Sotos Syndrome 1,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Disease Of Mental Health,Cholangiocarcinoma,Rhabdoid Cancer,Fragile X Syndrome,Lymphoma, Non-Hodgkin, Familial,Beckwith-Wiedemann Syndrome,Esophageal Cancer,Myelodysplastic Syndrome,Diffuse Large B-Cell Lymphoma,Ewing Sarcoma,Mantle Cell Lymphoma,Splenic Marginal Zone Lymphoma,Tongue Squamous Cell Carcinoma,Acute Promyelocytic Leukemia,Follicular Lymphoma,Ovarian Clear Cell Carcinoma,Nasopharyngeal Carcinoma,Lymphoma,Brain Glioma,Kabuki Syndrome 1,Juvenile Myelomonocytic Leukemia,Autosomal Dominant Non-Syndromic Intellectual Disability,Rett Syndrome,Myelofibrosis,Myeloma, Multiple,Medulloblastoma,Melanoma, Uveal,Childhood Acute Myeloid Leukemia,Lung Cancer,Hyperoxaluria, Primary, Type I,Pancreatic Cancer,Polycythemia Vera |
4mi5_a | Q15910 | ENSG00000106462 | EZH2 | 95.30 | 0.00018 | 2.10E-08 | 62.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YHR109W | CTM1 | SGDID:S000001151 | RBCMT |
Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplastic (EC 2.1.1.127) ([Fructose-bisphosphate aldolase]-lysine N-methyltransferase) (EC 2.1.1.259) ([Ribulose-bisphosphate carboxylase]-lysine N-methyltransferase) (PsLSMT) (RuBisCO LSMT) (RuBisCO methyltransferase) (rbcMT) |
2.1.1.127,2.1.1.259, | Pisum sativum | 2h21_b | Q43088 | 99.10 | 1.30E-14 | 1.60E-18 | 140.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| YHR109W | CTM1 | SGDID:S000001151 | SETD3 C14orf154 |
Actin-histidine N-methyltransferase (EC 2.1.1.85) (SET domain-containing protein 3) (hSETD3) |
2.1.1.85 | Homo sapiens | Meier-Gorlin Syndrome 1 |
6icv_b | Q86TU7 | ENSG00000183576 | SETD3 | 99.20 | 1.80E-15 | 2.20E-19 | 148.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YHR109W | CTM1 | SGDID:S000001151 | SETD6 |
N-lysine methyltransferase SETD6 (EC 2.1.1.-) (SET domain-containing protein 6) |
2.1.1.- | Homo sapiens | Familial Colorectal Cancer Type X,Meningioma, Familial |
3qxy_a | Q8TBK2 | ENSG00000103037 | SETD6 | 99.20 | 1.30E-15 | 1.50E-19 | 147.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YHR109W | CTM1 | SGDID:S000001151 | SMYD3 ZMYND1 ZNFN3A1 |
Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1) |
2.1.1.354 | Homo sapiens | Cerebellar Ataxia, Nonprogressive, With Mental Retardation,Renal Wilms' Tumor,Hepatocellular Carcinoma |
5v37_a | Q9H7B4 | ENSG00000185420 | SMYD3 | 98.40 | 4.30E-11 | 6.10E-15 | 106.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YHR109W | CTM1 | SGDID:S000001151 | KMT5A PRSET7 SET07 SET8 SETD8 |
N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine N-methyltransferase 5A) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8) |
2.1.1.361 | Homo sapiens | Meier-Gorlin Syndrome 1 |
5teg_a | Q9NQR1 | ENSG00000183955 | KMT5A | 95.20 | 0.00021 | 2.70E-08 | 56.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YHR109W | CTM1 | SGDID:S000001151 | SMYD2 KMT3C |
N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (HSKM-B) (Histone methyltransferase SMYD2) (EC 2.1.1.354) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2) |
2.1.1.354 | Homo sapiens | 4wuy_a | Q9NRG4 | ENSG00000143499 | SMYD2 | 98.40 | 3.70E-11 | 4.90E-15 | 111.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YHR109W | CTM1 | SGDID:S000001151 | set7 SPCC297.04c |
SET domain-containing protein 7 (EC 2.1.1.-) |
2.1.1.- | Schizosaccharomyces pombe | 5h6z_a | Q9Y7Q6 | 97.10 | 4.50E-07 | 5.60E-11 | 74.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| YHR109W | CTM1 | SGDID:S000001151 | PFAG_03779 |
PFAG_03779 |
Plasmodium falciparum | 4rz0_a | W7FLI1 | 95.60 | 9.00E-05 | 1.20E-08 | 57.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |